Molecular-pathological prognostic factors of gastric cancer: a review
暂无分享,去创建一个
Hirofumi Nakayama | Phyu Phyu Aung | N. Oue | S. Matsumura | H. Nakayama | W. Yasui | P. Aung | Naohide Oue | Wataru Yasui | Shunji Matsumura | Mariko Shutoh | Mariko Shutoh | Shunji Matsumura
[1] H. Yokozaki,et al. Genetic and epigenetic changes in stomach cancer. , 2001, International review of cytology.
[2] H. Bidd,et al. Abnormal expression of pRb, p16, and cyclin D1 in gastric adenocarcinoma and its lymph node metastases: relationship with pathological features and survival. , 2003, Human pathology.
[3] H. Yokozaki,et al. Molecular–pathological diagnosis of gastrointestinal tissues and its contribution to cancer histopathology , 1999, Pathology international.
[4] C B Harley,et al. Specific association of human telomerase activity with immortal cells and cancer. , 1994, Science.
[5] J. Yokota,et al. Genetic pathways to human cancer , 2003 .
[6] C. Moskaluk,et al. Gastric cancers overexpress S100A calcium-binding proteins. , 2002, Cancer research.
[7] H. Yokozaki,et al. Promoter hypermethylation of MGMT is associated with protein loss in gastric carcinoma , 2001, International journal of cancer.
[8] N. Oue,et al. A single nucleotide polymorphism in the transmembrane domain coding region of HER‐2 is associated with development and malignant phenotype of gastric cancer , 2003, International journal of cancer.
[9] Kazuhiro Yoshida,et al. Frequent epigenetic inactivation of RIZ1 by promoter hypermethylation in human gastric carcinoma , 2004, International journal of cancer.
[10] C. Caldas,et al. CDH1 c‐160a promotor polymorphism is not associated with risk of stomach cancer , 2002, International journal of cancer.
[11] A. Bosserhoff,et al. Cloning of a novel malignant melanoma-derived growth-regulatory protein, MIA. , 1994, Cancer research.
[12] Y. Chung,et al. Prognostic implications of microsatellite genotypes in gastric carcinoma , 2000, International journal of cancer.
[13] Hiroki Kuniyasu,et al. Molecular diagnosis of gastric cancer: present and future , 2001, Gastric Cancer.
[14] K. Mimori,et al. Prognostic score of gastric cancer determined by cDNA microarray. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[15] K. Hirata,et al. Mucin phenotype and microsatellite instability in early multiple gastric cancers , 2002, International journal of cancer.
[16] J. Vass,et al. Profiling, comparison and validation of gene expression in gastric carcinoma and normal stomach , 2003, Oncogene.
[17] C. Figdor,et al. De-novo expression of CD44 and survival in gastric cancer , 1993, The Lancet.
[18] E. Tahara. Molecular mechanism of stomach carcinogenesis , 2005, Journal of Cancer Research and Clinical Oncology.
[19] Kazuhiro Yoshida,et al. Epigenetic inactivation of SOCS‐1 by CpG island hypermethylation in human gastric carcinoma , 2004, International journal of cancer.
[20] S. Baylin,et al. Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype. , 1999, Cancer research.
[21] H. Höfler,et al. Gastric adenocarcinoma: pathomorphology and molecular pathology , 2001, Journal of Cancer Research and Clinical Oncology.
[22] Kazuhiro Yoshida,et al. Expression of POT1 is Associated with Tumor Stage and Telomere Length in Gastric Carcinoma , 2004, Cancer Research.
[23] S. Leung,et al. Soluble E-cadherin is a valid prognostic marker in gastric carcinoma , 2001, Gut.
[24] G. Hommel,et al. Prognostic value and clinicopathological profile of microsatellite instability in gastric cancer. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.
[25] D. Pinkel,et al. Genomic Alterations in Primary Gastric Adenocarcinomas Correlate with Clinicopathological Characteristics and Survival , 2004, Cellular oncology : the official journal of the International Society for Cellular Oncology.
[26] S. Hirohashi,et al. Clinical Significance of Dysadherin Expression in Gastric Cancer Patients , 2004, Clinical Cancer Research.
[27] Shuichi Tsutsumi,et al. Global gene expression analysis of gastric cancer by oligonucleotide microarrays. , 2002, Cancer research.
[28] M. Mori,et al. Microsatellite instability in multiple gastric cancers , 1995, International journal of cancer.
[29] R. Seruca,et al. Microsatellite instability at multiple loci in gastric carcinoma: clinicopathologic implications and prognosis. , 1996, Gastroenterology.
[30] Kazuhiro Yoshida,et al. Frequent Loss of RUNX3 Expression by Promoter Hypermethylation in Gastric Carcinoma , 2004, Pathobiology.
[31] K. Chayama,et al. Interleukin 8 and vascular endothelial growth factor -- prognostic factors in human gastric carcinomas? , 2001, European journal of cancer.
[32] H. Yokozaki,et al. Correlation of a single nucleotide polymorphism in the E-cadherin gene promoter with tumorigenesis and progression of gastric carcinoma in Japan. , 2003, International journal of oncology.
[33] C. Fondevila,et al. p53 and VEGF expression are independent predictors of tumour recurrence and survival following curative resection of gastric cancer , 2004, British Journal of Cancer.
[34] T. Inoue,et al. Matrix metalloproteinase-1 expression is a prognostic factor for patients with advanced gastric cancer. , 1999, International journal of molecular medicine.
[35] A. Bosserhoff,et al. Functional role of MIA in melanocytes and early development of melanoma , 2004, Oncogene.
[36] Yusuke Nakamura,et al. Genome-wide analysis of gene expression in intestinal-type gastric cancers using a complementary DNA microarray representing 23,040 genes. , 2002, Cancer research.
[37] I. Fidler,et al. Expression of interleukin-8 correlates with vascularity in human gastric carcinomas. , 1998, The American journal of pathology.
[38] Kazuhiro Yoshida,et al. A single nucleotide polymorphism in the MMP-1 promoter is correlated with histological differentiation of gastric cancer , 2004, Journal of Cancer Research and Clinical Oncology.
[39] Chien-Jen Chen,et al. Association of the −160 C → a promoter polymorphism of E‐cadherin gene with gastric carcinoma risk , 2002, Cancer.
[40] Ji-yeon Lee,et al. Analysis of gene expression profiles of gastric normal and cancer tissues by SAGE. , 2003, Genomics.
[41] N. Tomita,et al. Expression of Tumor Suppressor Gene p16INK4 Products in Primary Gastric Cancer , 2000, Oncology.
[42] Y. Mitani,et al. Histone Acetylation and Gastrointestinal Carcinogenesis , 2003, Annals of the New York Academy of Sciences.
[43] Kazuhiro Yoshida,et al. A single nucleotide polymorphism in the MMP-9 promoter affects tumor progression and invasive phenotype of gastric cancer , 2004, Journal of Cancer Research and Clinical Oncology.
[44] J. Fujimoto,et al. Immunohistochemical Detection of Human Telomerase Reverse Transcriptase in Normal Mucosa and Precancerous Lesions of the Stomach , 1999, Japanese journal of cancer research : Gann.
[45] H. Yokozaki,et al. Distinct promoter hypermethylation of p16INK4a, CDH1, and RAR‐beta in intestinal, diffuse–adherent, and diffuse–scattered type gastric carcinomas , 2002, The Journal of pathology.
[46] L. David,et al. Clinicopathological significance and survival influence of p53 protein expression in gastric carcinoma , 2004, Histopathology.
[47] K. Hioki,et al. Increased expression of CD44v6 mRNA significantly correlates with distant metastasis and poor prognosis in gastric cancer , 1998, International journal of cancer.
[48] Kazuhiro Yoshida,et al. A Single Nucleotide Polymorphism in the 5′ Untranslated Region of the EGF Gene Is Associated with Occurrence and Malignant Progression of Gastric Cancer , 2005, Pathobiology.
[49] Y. Mitani,et al. Gene Expression Profile of Gastric Carcinoma , 2004, Cancer Research.
[50] I. Fidler. Critical Determinants of Human Colon Cancer Metastasis , 1997 .
[51] N. Oue,et al. Reduced Expression of the TSP1 Gene and Its Association with Promoter Hypermethylation in Gastric Carcinoma , 2003, Oncology.
[52] K. Naka,et al. Effect of trichostatin A on cell growth and expression of cell cycle‐ and apoptosis‐related molecules in human gastric and oral carcinoma cell lines , 2000, International journal of cancer.
[53] R. Hamelin,et al. Gastric carcinomas with microsatellite instability: clinical features and mutations to the TGF‐β type II receptor, IGFII receptor, and BAX genes , 1999, The Journal of pathology.
[54] S. Tsujitani,et al. Serum concentration of CD44 variant 6 and its relation to prognosis in patients with gastric carcinoma , 1998, Cancer.
[55] Ji Huang,et al. [Serial analysis of gene expression]. , 2002, Yi chuan = Hereditas.
[56] L. Ellis,et al. Significance of platelet-derived endothelial cell growth factor in the angiogenesis of human gastric cancer. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.
[57] 三谷 佳嗣. Histone H3 acetylation is associated with reduced p21WAF1/CIP1 expression by gastric carcinoma , 2006 .
[58] K. Mimori,et al. Clinical significance of tissue inhibitor of metalloproteinase expression in gastric carcinoma. , 1997, British Journal of Cancer.
[59] L. Ellis,et al. Significance of vessel count and vascular endothelial growth factor and its receptor (KDR) in intestinal-type gastric cancer. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.
[60] Hirofumi Nakayama,et al. Search for new biomarkers of gastric cancer through serial analysis of gene expression and its clinical implications , 2004, Cancer science.
[61] Y. Okada,et al. Expression and tissue localization of matrix metalloproteinase 7 (matrilysin) in human gastric carcinomas. Implications for vessel invasion and metastasis , 1998, International journal of cancer.
[62] Kazuhiro Yoshida,et al. DNA hypermethylation and histone hypoacetylation of the HLTF gene are associated with reduced expression in gastric carcinoma , 2003, Cancer science.
[63] G. Capellá,et al. Genetic susceptibility and gastric cancer risk , 2002, International journal of cancer.
[64] K. Mimori,et al. Analysis of MT1‐MMP and MMP2 expression in human gastric cancers , 1997, International journal of cancer.
[65] S. Natsugoe,et al. The cooperative role of p27 with cyclin E in the prognosis of advanced gastric carcinoma , 2000, Cancer.
[66] W. Stolz,et al. Melanoma-inhibiting activity, a novel serum marker for progression of malignant melanoma. , 1997, Cancer research.
[67] Y. Nakamura,et al. Frequent replication errors at microsatellite loci in tumors of patients with multiple primary cancers. , 1994, Cancer Research.